FREE NEJM E-TOC    HOME   |   SUBSCRIBE   |   CURRENT ISSUE   |   PAST ISSUES   |   COLLECTIONS   |   Search Term  Advanced Search

Sign in | Get NEJM's E-Mail Table of Contents — Free | Subscribe

Previous Volume 354:2729-2731 June 22, 2006 Number 25 Next

	Since this article has no abstract, we have provided an extract of the first 100 words of the full text and any section headings.

	Full Text PDF PDA Full Text Purchase this article Add to Personal Archive Add to Citation Manager Notify a Friend E-mail When Cited E-mail When Letters Appear PubMed Citation

To the Editor: Pheochromocytoma occurs in approximately 1 percent of patients with neurofibromatosis type 1.¹ Accordingly, germ-line mutations in the NF1 gene — the susceptibility gene for neurofibromatosis type 1 — are assumed to be one of the heritable causes of pheochromocytoma.²

Given the previous lack of relevant molecular data, we established and analyzed a registry for patients with neurofibromatosis type 1 and pheochromocytoma in collaboration with colleagues from 20 centers in Germany, other European countries, and the United States. We compared the findings for patients with neurofibromatosis type 1 with those for patients with other pheochromocytoma-related syndromes, including von . . . [Full Text of this Article]

This article has been cited by other articles:

• Yuan, W., Wang, W., Cui, B., Su, T., Ge, Y., Jiang, L., Zhou, W., Ning, G. (2008). Overexpression of ERBB-2 was more frequently detected in malignant than benign pheochromocytomas by multiplex ligation-dependent probe amplification and immunohistochemistry. Endocr Relat Cancer 15: 343-350 [Abstract] [Full Text]  
• Neumann, H. P.H., Vortmeyer, A., Schmidt, D., Werner, M., Erlic, Z., Cascon, A., Bausch, B., Januszewicz, A., Eng, C. (2007). Evidence of MEN-2 in the Original Description of Classic Pheochromocytoma. NEJM 357: 1311-1315 [Abstract] [Full Text]  
• Bausch, B., Borozdin, W., Mautner, V. F., Hoffmann, M. M., Boehm, D., Robledo, M., Cascon, A., Harenberg, T., Schiavi, F., Pawlu, C., Peczkowska, M., Letizia, C., Calvieri, S., Arnaldi, G., Klingenberg-Noftz, R. D., Reisch, N., Fassina, A., Brunaud, L., Walter, M. A., Mannelli, M., MacGregor, G., Palazzo, F. F., Barontini, M., Walz, M. K., Kremens, B., Brabant, G., Pfaffle, R., Koschker, A.-C., Lohoefner, F., Mohaupt, M., Gimm, O., Jarzab, B., McWhinney, S. R., Opocher, G., Januszewicz, A., Kohlhase, J., Eng, C., Neumann, H. P. H., for the European-American Phaeochromocytoma Regist, (2007). Germline NF1 Mutational Spectra and Loss-of-Heterozygosity Analyses in Patients with Pheochromocytoma and Neurofibromatosis Type 1. J. Clin. Endocrinol. Metab. 92: 2784-2792 [Abstract] [Full Text]  
• Ferner, R. E, Huson, S. M, Thomas, N., Moss, C., Willshaw, H., Evans, D G., Upadhyaya, M., Towers, R., Gleeson, M., Steiger, C., Kirby, A. (2007). Guidelines for the diagnosis and management of individuals with neurofibromatosis 1. J. Med. Genet. 44: 81-88 [Abstract] [Full Text]  
• Bausch, B., Koschker, A.-C., Fassnacht, M., Stoevesandt, J., Hoffmann, M. M., Eng, C., Allolio, B., Neumann, H. P. H. (2006). Comprehensive Mutation Scanning of NF1 in Apparently Sporadic Cases of Pheochromocytoma. J. Clin. Endocrinol. Metab. 91: 3478-3481 [Abstract] [Full Text]